Abstract:

A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established to quantify sialic acid (N-acetylneuraminic acid, NANA) from lipoproteins and human plasma. The method was used to investigate the different contents of NANA from lipoproteins between diabetic with an average age of 51.6 years and healthy participants with an average age of 50.7 years. The NANA from lipoprotein samples was hydrolyzed by acetic acid (pH=2) at 80 ℃ for 2 h and analyzed by the optimized LC-MS/MS method after high speed centrifugation and filtration. The limits of detection and quantification of NANA were 7.4 and 24.5 pg, respectively. The linear range was 2.5-80 ng/mL for NANA and the correlation coefficient (R²) was more than 0.998. The levels of NANA in the plasma of type Ⅱ diabetics and healthy participants were (548.3±88.9) and (415.3±55.5) mg/L, respectively; and the levels of NANA from very low density lipoproteins (VLDL), low density lipoproteins (LDL), and high density lipoproteins (HDL) of the type Ⅱ diabetics and the healthy participants were (4.91±0.19), (6.95±0.28), (3.61±0.22) μg/mg and (2.90±0.27), (7.03±0.04), (2.40±0.09) μg/mg, respectively. The sialic acid levels of VLDL and HDL from the type Ⅱ diabetics were markedly higher than those of the corresponding healthy participants with the similar ages (P<0.01). The method can rapidly determine the sialic acid from lipoproteins, and is reproducible and time saving.

Key words: diabetes mellitus, human plasma, lipoprotein, liquid chromatography-tandem mass spectrometry (LC-MS/MS), sialic acid